BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 16023344)

  • 1. Lipophilic versus hydrogen-bonding effect in P3 on potency and selectivity of valine aspartyl ketones as caspase 3 inhibitors.
    Mellon C; Aspiotis R; Black CW; Bayly CI; Grimm EL; Giroux A; Han Y; Isabel E; McKay DJ; Nicholson DW; Rasper DM; Roy S; Tam J; Thornberry NA; Vaillancourt JP; Xanthoudakis S; Zamboni R
    Bioorg Med Chem Lett; 2005 Sep; 15(17):3886-90. PubMed ID: 16023344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dipeptidyl aspartyl fluoromethylketones as potent caspase inhibitors: SAR of the N-protecting group.
    Cai SX; Guan L; Jia S; Wang Y; Yang W; Tseng B; Drewe J
    Bioorg Med Chem Lett; 2004 Nov; 14(21):5295-300. PubMed ID: 15454214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dipeptidyl aspartyl fluoromethylketones as potent caspase inhibitors: peptidomimetic replacement of the P(2) amino acid by 2-aminoaryl acids and other non-natural amino acids.
    Wang Y; Jia S; Tseng B; Drewe J; Cai SX
    Bioorg Med Chem Lett; 2007 Nov; 17(22):6178-82. PubMed ID: 17889532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dipeptidyl aspartyl fluoromethylketones as potent caspase inhibitors: peptidomimetic replacement of the P2 alpha-amino acid by a alpha-hydroxy acid.
    Wang Y; Guan L; Jia S; Tseng B; Drewe J; Cai SX
    Bioorg Med Chem Lett; 2005 Mar; 15(5):1379-83. PubMed ID: 15713391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicotinyl aspartyl ketones as inhibitors of caspase-3.
    Isabel E; Black WC; Bayly CI; Grimm EL; Janes MK; McKay DJ; Nicholson DW; Rasper DM; Renaud J; Roy S; Tam J; Thornberry NA; Vaillancourt JP; Xanthoudakis S; Zamboni R
    Bioorg Med Chem Lett; 2003 Jul; 13(13):2137-40. PubMed ID: 12798321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of novel aspartyl ketone dipeptides as potent and selective caspase-3 inhibitors.
    Han Y; Giroux A; Grimm EL; Aspiotis R; Francoeur S; Bayly CI; Mckay DJ; Roy S; Xanthoudakis S; Vaillancourt JP; Rasper DM; Tam J; Tawa P; Thornberry NA; Paterson EP; Garcia-Calvo M; Becker JW; Rotonda J; Nicholson DW; Zamboni RJ
    Bioorg Med Chem Lett; 2004 Feb; 14(3):805-8. PubMed ID: 14741294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dipeptidyl aspartyl fluoromethylketones as potent caspase-3 inhibitors: SAR of the P2 amino acid.
    Wang Y; Huang JC; Zhou ZL; Yang W; Guastella J; Drewe J; Cai SX
    Bioorg Med Chem Lett; 2004 Mar; 14(5):1269-72. PubMed ID: 14980679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationships within a series of caspase inhibitors. Part 2: Heterocyclic warheads.
    Ullman BR; Aja T; Chen N; Diaz JL; Gu X; Herrmann J; Kalish VJ; Karanewsky DS; Kodandapani L; Krebs JJ; Linton SD; Meduna SP; Nalley K; Robinson ED; Roggo SP; Sayers RO; Schmitz A; Ternansky RJ; Tomaselli KJ; Wu JC
    Bioorg Med Chem Lett; 2005 Aug; 15(15):3632-6. PubMed ID: 15964758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using peptidic inhibitors to systematically probe the S1' site of caspase-3 and caspase-7.
    Goode DR; Sharma AK; Hergenrother PJ
    Org Lett; 2005 Aug; 7(16):3529-32. PubMed ID: 16048334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solid phase synthesis of selective caspase-3 peptide inhibitors.
    Grimm EL; Roy B; Aspiotis R; Bayly CI; Nicholson DW; Rasper DM; Renaud J; Roy S; Tam J; Tawa P; Vaillancourt JP; Xanthoudakis S; Zamboni RJ
    Bioorg Med Chem; 2004 Mar; 12(5):845-51. PubMed ID: 14980595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxamyl dipeptide caspase inhibitors developed for the treatment of stroke.
    Linton SD; Aja T; Allegrini PR; Deckwerth TL; Diaz JL; Hengerer B; Herrmann J; Jahangiri KG; Kallen J; Karanewsky DS; Meduna SP; Nalley K; Robinson ED; Roggo S; Rovelli G; Sauter A; Sayers RO; Schmitz A; Smidt R; Ternansky RJ; Tomaselli KJ; Ullman BR; Wiessner C; Wu JC
    Bioorg Med Chem Lett; 2004 May; 14(10):2685-91. PubMed ID: 15109679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trifluoroethylamines as amide isosteres in inhibitors of cathepsin K.
    Black WC; Bayly CI; Davis DE; Desmarais S; Falgueyret JP; Léger S; Li CS; Massé F; McKay DJ; Palmer JT; Percival MD; Robichaud J; Tsou N; Zamboni R
    Bioorg Med Chem Lett; 2005 Nov; 15(21):4741-4. PubMed ID: 16154747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and evaluation of novel dipeptidyl benzoyloxymethyl ketones as caspase inhibitors.
    Nedev HN; Klaiman G; LeBlanc A; Saragovi HU
    Biochem Biophys Res Commun; 2005 Oct; 336(2):397-400. PubMed ID: 16137654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reducing the peptidyl features of caspase-3 inhibitors: a structural analysis.
    Becker JW; Rotonda J; Soisson SM; Aspiotis R; Bayly C; Francoeur S; Gallant M; Garcia-Calvo M; Giroux A; Grimm E; Han Y; McKay D; Nicholson DW; Peterson E; Renaud J; Roy S; Thornberry N; Zamboni R
    J Med Chem; 2004 May; 47(10):2466-74. PubMed ID: 15115390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1,3-Dioxo-4-methyl-2,3-dihydro-1H-pyrrolo[3,4-c]quinolines as potent caspase-3 inhibitors.
    Kravchenko DV; Kysil VV; Ilyn AP; Tkachenko SE; Maliarchouk S; Okun IM; Ivachtchenko AV
    Bioorg Med Chem Lett; 2005 Apr; 15(7):1841-5. PubMed ID: 15780618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solid-phase analogue synthesis of caspase-3 inhibitors via palladium-catalyzed amination of 3-bromopyrazinones.
    Isabel E; Aspiotis R; Black WC; Colucci J; Fortin R; Giroux A; Grimm EL; Han Y; Mellon C; Nicholson DW; Rasper DM; Renaud J; Roy S; Tam J; Tawa P; Vaillancourt JP; Xanthoudakis S; Zamboni RJ
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1671-4. PubMed ID: 17251019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In situ assembly of enzyme inhibitors using extended tethering.
    Erlanson DA; Lam JW; Wiesmann C; Luong TN; Simmons RL; DeLano WL; Choong IC; Burdett MT; Flanagan WM; Lee D; Gordon EM; O'Brien T
    Nat Biotechnol; 2003 Mar; 21(3):308-14. PubMed ID: 12563278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlating the fractional inhibition of caspase-3 in NT2 cells with apoptotic markers using an active-caspase-3 enzyme-linked immunosorbent assay.
    Tawa P; Giroux A; Grimm E; Han Y; Nicholson DW; Xanthoudakis S
    Anal Biochem; 2006 Mar; 350(1):32-40. PubMed ID: 16430849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dipeptide nitrile inhibitors of cathepsin K.
    Altmann E; Aichholz R; Betschart C; Buhl T; Green J; Lattmann R; Missbach M
    Bioorg Med Chem Lett; 2006 May; 16(9):2549-54. PubMed ID: 16480867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel trifluoromethyl ketones as potent gastric lipase inhibitors.
    Kokotos G; Kotsovolou S; Verger R
    Chembiochem; 2003 Jan; 4(1):90-5. PubMed ID: 12512081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.